dc.contributor.author
Rotter, Gabriele
dc.contributor.author
Fernholz, Isabel
dc.contributor.author
Binting, Sylvia
dc.contributor.author
Keller, Theresa
dc.contributor.author
Roll, Stephanie
dc.contributor.author
Kass, Benjamin
dc.contributor.author
Reinhold, Thomas
dc.contributor.author
Willich, Stefan N.
dc.contributor.author
Schmidt, Alexander
dc.contributor.author
Brinkhaus, Benno
dc.date.accessioned
2021-04-27T08:50:24Z
dc.date.available
2021-04-27T08:50:24Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/30554
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-30294
dc.description.abstract
Background: Nonspecific chronic neck pain (cNP) is common in adult violinists and violists
and is often treated with osteopathic medicine (OM), although the effectiveness of this
treatment has not been determined to date. This study aimed to evaluate the effectiveness and
safety of OM in adult violinists and violists with cNP.
Methods: In a two-armed randomized controlled single-center open trial, adult violinists
and violists, including music students, with cNP (⩾12 weeks) were randomized to either
five individualized OM sessions (OM group) or to no intervention (control group, CG) in the
outpatient clinic for integrative medicine, Charité - Universitätsmedizin Berlin, Germany.
All patients received a musicians’ medicine consultation and paracetamol on demand. The
primary outcome parameter was the neck pain intensity on a visual analog scale (VAS, 0–
100 mm, 0 = no pain, 100 = worst imaginable pain) after 12 weeks. Secondary outcomes included
neck pain disability (Neck Disability Index, NDI, 0–100%) after 12 weeks. The last follow-up visit
was after 52 weeks. Statistical analysis included analysis of covariance adjusted for respective
baseline value.
Results: Altogether, 62 outpatients were included [OM group (n = 28), CG (n = 34); 81% female;
mean age, 41.6 ± 11.1 years; mean baseline neck pain, 55.9 ± 11.6 mm]. After 12 weeks, OM
was associated with an improvement in the OM group versus the CG in neck pain on the VAS
[14.6 mm (95% confidence interval 8.0; 21.2) versus 40.8 mm (34.7; 46.9), p < 0.001, Cohen’s
d = 1.4], and neck pain disability as determined by the NDI [8.8% (6.7; 10.8) versus 17.2% (15.3;
19.1), p < 0.001]. Some improvements were maintained until 52 weeks of follow-up. No serious
adverse events were observed.
Conclusions: The results of this study suggest that OM might be effective in reducing
pain intensity in adult violinists and violists with nonspecific cNP. Further studies should
investigate the efficacy of OM in comparison with a sham procedure and with other effective
therapy methods in high-quality multicenter trials.
Trial registration: WHO Trial Registration
https://apps.who.int/trialsearch/NoAccess.aspx?aspxerrorpath=/trialsearch/Trial2.aspx by
German Clinical Trials Register DRKS00009258, Universal Trial Number (UTN): U1111-1173-
5943.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
complementary medicine
en
dc.subject
ostheopathic medicine
en
dc.subject
randomized controlled trial
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
The effect of osteopathic medicine on pain in musicians with nonspecific chronic neck pain: a randomized controlled trial
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1177/1759720x20979853
dcterms.bibliographicCitation.journaltitle
Therapeutic Advances in Musculoskeletal Disease
dcterms.bibliographicCitation.originalpublishername
SAGE Publications
dcterms.bibliographicCitation.volume
12
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.issn
1759-720X
dcterms.isPartOf.eissn
1759-7218